Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
548.4 INR | -0.69% | +0.40% | +28.09% |
04-02 | Windlas Biotech Commissions New Injectible Manufacturing Unit | MT |
04-02 | Windlas Biotech Limited Commissions Its Injectable Facility | CI |
Sales 2022 | 4.66B 55.85M 4.45B | Sales 2023 | 5.13B 61.5M 4.9B | Capitalization | 4.71B 56.51M 4.5B |
---|---|---|---|---|---|
Net income 2022 | 381M 4.57M 364M | Net income 2023 | 426M 5.11M 407M | EV / Sales 2022 | 0.62 x |
Net cash position 2022 | 1.69B 20.3M 1.62B | Net cash position 2023 | 1.27B 15.22M 1.21B | EV / Sales 2023 | 0.67 x |
P/E ratio 2022 |
11.3
x | P/E ratio 2023 |
11.4
x | Employees | 1,049 |
Yield 2022 |
1.67% | Yield 2023 |
1.78% | Free-Float | 37.18% |
1 day | -0.69% | ||
1 week | +0.40% | ||
Current month | -0.63% | ||
1 month | -0.63% | ||
3 months | +17.00% | ||
6 months | +50.87% | ||
Current year | +28.09% |
Managers | Title | Age | Since |
---|---|---|---|
Komal Gupta
CEO | Chief Executive Officer | - | 15/10/15 |
Founder | 73 | 31/12/00 | |
Compliance Officer | - | 17/03/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 05/05/21 | |
Director/Board Member | 47 | 03/05/21 | |
Founder | 73 | 31/12/00 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 548.4 | -0.69% | 4,884 |
02/05/24 | 552.2 | +0.05% | 3,997 |
30/04/24 | 551.9 | +0.52% | 10,880 |
29/04/24 | 549 | +0.52% | 3,509 |
26/04/24 | 546.2 | -0.67% | 3,529 |
Delayed Quote Bombay S.E., May 03, 2024 at 11:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- WINDLAS Stock
- WINDLAS Stock